Strategies for Assessing and Addressing Confounding
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Relative Risk
Hazard Rate
Factors Affecting the Risk of Infection
Actuarial Approach
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 29, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
1School of Health and Human Sciences (Egger), Southern Cross University, Lismore, New South Wales, Australia; Clinical Obesity Research (Dixon), Baker IDI Heart and Diabetes Institute, Melbourne Australia; Primary Care Research Unit (Dixon), Monash University, Melbourne, Australia. eggergj@ozemail.com.au.
No abstract available in PubMed .